{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:12:51Z","timestamp":1775560371380,"version":"3.50.1"},"reference-count":31,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3934\/mbe.2026050","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:32:41Z","timestamp":1775557961000},"page":"1356-1374","source":"Crossref","is-referenced-by-count":0,"title":["Effect of drug resistance on an HIV epidemic in heterogeneous populations"],"prefix":"10.3934","volume":"23","author":[{"given":"Roberto A.","family":"Saenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Sciences, Universidad de Colima, Colima, Mexico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2026050-1","unstructured":"Joint United Nations Programme on HIV\/AIDS<\/i>, Global HIV & AIDS Statistics\u2014Fact Sheet<\/i>, 2025. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/2025-07\/2025_Global_HIV_Factsheet_en.pdf<\/ext-link>."},{"key":"key-10.3934\/mbe.2026050-2","unstructured":"Joint United Nations Programme on HIV\/AIDS<\/i>, World AIDS Day Report<\/i>, 2011. Available from: http:\/\/www.unaids.org\/en\/resources\/documents\/2011\/<\/ext-link>."},{"key":"key-10.3934\/mbe.2026050-3","doi-asserted-by":"publisher","unstructured":"M. S. Cohen, Y. Q. Chen, M. McCauley, T. Gamble, M. C. Hosseinipour, N. Kumarasamy, et al., Prevention of HIV-1 infection with early antiretroviral therapy, N. Engl. J. Med.<\/i>, 365<\/b> (2011), 493\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1105243","DOI":"10.1056\/NEJMoa1105243"},{"key":"key-10.3934\/mbe.2026050-4","unstructured":"World Health Organization<\/i>, Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for A Public Health Approach<\/i>, 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240031593<\/ext-link>."},{"key":"key-10.3934\/mbe.2026050-5","doi-asserted-by":"publisher","unstructured":"A. H. Peruski, B. Wu, L. Linley, K. P. Delaney, E. A. DiNenno, A. S. Johnson, Time from HIV infection to diagnosis in the U.S., 2014\u20132018, Am. J. Prev. Med.<\/i>, 61<\/b> (2021), 636\u2013643. https:\/\/doi.org\/10.1016\/j.amepre.2021.04.015","DOI":"10.1016\/j.amepre.2021.04.015"},{"key":"key-10.3934\/mbe.2026050-6","doi-asserted-by":"publisher","unstructured":"F. Clavel, A. J. Hance, HIV drug resistance, N. Engl. J. Med.<\/i>, 350<\/b> (2004), 1023\u20131035. https:\/\/doi.org\/10.1056\/NEJMra025195","DOI":"10.1056\/NEJMra025195"},{"key":"key-10.3934\/mbe.2026050-7","doi-asserted-by":"publisher","unstructured":"S. Margeridon-Thermet, R. W. Shafer, Comparison of the mechanisms of drug resistance among HIV, hepatitis B, and hepatitis C, Viruses<\/i>, 2<\/b> (2010), 2696\u20132739. https:\/\/doi.org\/10.3390\/v2122696","DOI":"10.3390\/v2122696"},{"key":"key-10.3934\/mbe.2026050-8","doi-asserted-by":"publisher","unstructured":"D. R. Bangsberg, E. P. Acosta, R. Gupta, D. Guzman, E. D. Riley, P. R. Harrigan, et al., Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness, AIDS<\/i>, 20<\/b> (2006), 223\u2013231. https:\/\/doi.org\/10.1097\/01.aids.0000199825.34241.49","DOI":"10.1097\/01.aids.0000199825.34241.49"},{"key":"key-10.3934\/mbe.2026050-9","doi-asserted-by":"crossref","unstructured":"R. M. Kagan, J. D. Baxter, T Kim, E. M. Marlowe, HIV-1 drug resistance trends in the era of modern antiretrovirals: 2018\u20132024, in Open Forum Infectious Diseases<\/i>, Oxford University Press, US, 12<\/b> (2025), 1\u20139. https:\/\/doi.org\/10.1093\/ofid\/ofaf446<\/ext-link>","DOI":"10.1093\/ofid\/ofaf446"},{"key":"key-10.3934\/mbe.2026050-10","doi-asserted-by":"publisher","unstructured":"S. Hu\u00e9, R. J. Gifford, D. Dunn, E. Fernhill, D. Pillay, Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals, J. Virol.<\/i>, 83<\/b> (2009), 2645\u20132654. https:\/\/doi.org\/10.1128\/JVI.01556-08","DOI":"10.1128\/JVI.01556-08"},{"key":"key-10.3934\/mbe.2026050-11","doi-asserted-by":"publisher","unstructured":"J. O. Wertheim, A. M. Oster, J. A. Johnson, W. M. Switzer, N. Saduvala, A. L. Hernandez, et al., Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network, Virus Evol.<\/i>, 3<\/b> (2017), 1\u201312. https:\/\/doi.org\/10.1093\/ve\/vex008","DOI":"10.1093\/ve\/vex008"},{"key":"key-10.3934\/mbe.2026050-12","doi-asserted-by":"publisher","unstructured":"R. F. Baggaley, G. P. Garnett, N. M. Ferguson, Modelling the impact of antiretroviral use in resource-poor settings, PLoS Med.<\/i>, 3<\/b> (2006), e124. https:\/\/doi.org\/10.1371\/journal.pmed.0030124","DOI":"10.1371\/journal.pmed.0030124"},{"key":"key-10.3934\/mbe.2026050-13","doi-asserted-by":"crossref","unstructured":"S. Blower, E. Bodine, J. Kahn, W. McFarland, The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models, AIDS<\/i>, 19<\/b> (2005), 1\u201314.","DOI":"10.1097\/00002030-200501030-00001"},{"key":"key-10.3934\/mbe.2026050-14","doi-asserted-by":"publisher","unstructured":"R. A. Saenz, S. Bonhoeffer, Nested model reveals potential amplification of an HIV epidemic due to drug resistance, Epidemics<\/i>, 5<\/b> (2013), 34\u201343. https:\/\/doi.org\/10.1016\/j.epidem.2012.11.002","DOI":"10.1016\/j.epidem.2012.11.002"},{"key":"key-10.3934\/mbe.2026050-15","doi-asserted-by":"publisher","unstructured":"M. Shen, Y. Xiao, L. Rong, L. A. Meyers, S. E. Bellan, Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance, Proc. R. Soc. B<\/i>, 284<\/b> (2017), 20170525. https:\/\/doi.org\/10.1098\/rspb.2017.0525","DOI":"10.1098\/rspb.2017.0525"},{"key":"key-10.3934\/mbe.2026050-16","doi-asserted-by":"publisher","unstructured":"V. Supervie, M. Barret, J. S. Kahn, G. Musuka, T. L. Moeti, L. Busang, et al., Modeling dynamic interactions between pre-exposure prophilaxis interventions and treatment programs: Predicting HIV transmission and resistance, Sci. Rep.<\/i>, 1<\/b> (2011), 185. https:\/\/doi.org\/10.1038\/srep00185","DOI":"10.1038\/srep00185"},{"key":"key-10.3934\/mbe.2026050-17","doi-asserted-by":"publisher","unstructured":"B. G. Wagner, S. Blower, Universal access to HIV treatment versus universal 'test and treat': Transmission, drug resistance and treatment costs, PLoS One<\/i>, 7<\/b> (2012), e41212. https:\/\/doi.org\/10.1371\/journal.pone.0041212","DOI":"10.1371\/journal.pone.0041212"},{"key":"key-10.3934\/mbe.2026050-18","doi-asserted-by":"publisher","unstructured":"C. Fraser, T. D. Hollingsworth, R. Chapman, F. de Wolf, W. P. Hanage, Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis, Proc. Natl. Acad. Sci.<\/i>, 104<\/b> (2007), 17441\u201317446. https:\/\/doi.org\/10.1073\/pnas.0708559104","DOI":"10.1073\/pnas.0708559104"},{"key":"key-10.3934\/mbe.2026050-19","unstructured":"When To Start Consortium<\/i>, Timing of initiation of antiretroviral therapy in AIDS-free HIV-1- infected patients: A collaborative analysis of 18 HIV cohort studies, Lancet<\/i>, 373<\/b> (2009), 1352\u20131363. https:\/\/doi.org\/10.1016\/S0140-6736(09)60612-7<\/ext-link>"},{"key":"key-10.3934\/mbe.2026050-20","doi-asserted-by":"publisher","unstructured":"J. M. Heffernan, L. M. Wahl, Monte Carlo estimates of natural variation in HIV infection, J. Theor. Biol.<\/i>, 236<\/b> (2005), 137\u2013153. https:\/\/doi.org\/10.1016\/j.jtbi.2005.03.002","DOI":"10.1016\/j.jtbi.2005.03.002"},{"key":"key-10.3934\/mbe.2026050-21","doi-asserted-by":"publisher","unstructured":"L. J. S. Allen, A. M. Burgin, Comparison of deterministic and stochastic SIS and SIR models in discrete time, Math. Biosci.<\/i>, 163<\/b> (2000), 1\u201333. https:\/\/doi.org\/10.1016\/S0025-5564(99)00047-4","DOI":"10.1016\/S0025-5564(99)00047-4"},{"key":"key-10.3934\/mbe.2026050-22","doi-asserted-by":"publisher","unstructured":"T. D. Hollingsworth, R. M. Anderson, C. Fraser, HIV-1 transmission, by stage of infection, J. Infect. Dis.<\/i>, 198<\/b> (2008), 687\u2013693. https:\/\/doi.org\/10.1086\/590501","DOI":"10.1086\/590501"},{"key":"key-10.3934\/mbe.2026050-23","doi-asserted-by":"crossref","unstructured":"The UK Collaborative HIV Cohort (CHIC) Study Steering Committee<\/i>, HIV diagnosis at CD4 count above 500 cells\/mm$^3$ and progression to below 350 cells\/mm$^3$ without antiretroviral therapy, J. Acquir. Inmune Defic. Syndr.<\/i>, 46<\/b> (2007), 275\u2013278. https:\/\/doi.org\/10.1097\/QAI.0b013e3181514441","DOI":"10.1097\/QAI.0b013e3181514441"},{"key":"key-10.3934\/mbe.2026050-24","doi-asserted-by":"publisher","unstructured":"J. Martinez-Picado, M. A. Martinez, HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A review from the clinic and ex vivo, Virus Res.<\/i>, 134<\/b> (2008), 104\u2013123. https:\/\/doi.org\/10.1016\/j.virusres.2007.12.021","DOI":"10.1016\/j.virusres.2007.12.021"},{"key":"key-10.3934\/mbe.2026050-25","doi-asserted-by":"publisher","unstructured":"J. M. Kitayimbwa, J. Y. T. Mugisha, R. A. Saenz, Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains, Theor. Popul. Biol.<\/i>, 112<\/b> (2016), 33\u201342. https:\/\/doi.org\/10.1016\/j.tpb.2016.08.001","DOI":"10.1016\/j.tpb.2016.08.001"},{"key":"key-10.3934\/mbe.2026050-26","doi-asserted-by":"publisher","unstructured":"J. M. Kitayimbwa, J. Y. T. Mugisha, R. A. Saenz, The role of backward mutations on the within-host dynamics of HIV-1, J. Math. Biol.<\/i>, 67<\/b> (2013), 1111\u20131139. https:\/\/doi.org\/10.1007\/s00285-012-0581-2","DOI":"10.1007\/s00285-012-0581-2"},{"key":"key-10.3934\/mbe.2026050-27","doi-asserted-by":"publisher","unstructured":"V. Jain, M. C. Sucupira, P. Bacchetti, W. Hartogensis, R. S. Diaz, E. G. Kallas, et al., Differential persistence of transmitted HIV-1 drug resistance mutation classes, J. Infect. Dis.<\/i>, 203<\/b> (2011), 1174\u20131181. https:\/\/doi.org\/10.1093\/infdis\/jiq167","DOI":"10.1093\/infdis\/jiq167"},{"key":"key-10.3934\/mbe.2026050-28","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents<\/i>, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, Department of Health and Human Services<\/i>, 2025. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv<\/ext-link>. Accessed: February, 2026."},{"key":"key-10.3934\/mbe.2026050-29","doi-asserted-by":"publisher","unstructured":"S. O. Gbadamosi, M. J. Trepka, R. Dawit, R. Jebai, D. M. Sheehan, A systematic review and meta-analysis to estimate the time from HIV infection to diagnosis for people with HIV, AIDS Rev.<\/i>, 24<\/b> (2022), 32\u201340. https:\/\/doi.org\/10.24875\/AIDSRev.21000007","DOI":"10.24875\/AIDSRev.21000007"},{"key":"key-10.3934\/mbe.2026050-30","doi-asserted-by":"publisher","unstructured":"M. Lipsitch, T. Cohen, M. Murray, B. R. Levin, Antiviral resistance and the control of pandemic influenza, PLoS Med.<\/i>, 4<\/b> (2007), e15. https:\/\/doi.org\/10.1371\/journal.pmed.0040015","DOI":"10.1371\/journal.pmed.0040015"},{"key":"key-10.3934\/mbe.2026050-31","doi-asserted-by":"publisher","unstructured":"S. M. Moghadas, C. S. Bowman, G. Rost, J. Wu, Population-wide emergence of antiviral resistance during pandemic influenza, PLoS One<\/i>, 3<\/b> (2008), e1839. https:\/\/doi.org\/10.1371\/journal.pone.0001839","DOI":"10.1371\/journal.pone.0001839"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026050?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:32:43Z","timestamp":1775557963000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2026050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2026050","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}